Aging, energy, and oxidative stress in neurodegenerative diseases
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
The etiology of neurodegenerative diseases remains enigmatic; however, evidence for defects in energy metabolism, excitotoxicity, and for oxidative damage is increasingly compelling. It is likely that there is a complex interplay between these mechanisms. A defect in energy metabolism may lead to neuronal depolarization, activation of N‐methyl‐D‐aspartate excitatory amino acid‐receptors, and increases in intracellular calcium, which are buffered by mitochondria. Mitochondria are the major intracellular source of free radicals, and increased mitochondrial calcium concentrations enhance free radical generation. Mitochondrial DNA is particularly susceptible to oxidative stress, and there is evidence of age‐dependent damage and deterioration of respiratory enzyme activities with normal aging. This may contribute to the delayed onset and age dependence of neurodegenerative diseases. There is evidence for increased oxidative damage to macromolecules in amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, and Alzheimer's disease. Potential therapeutic approaches include glutamate release inhibitors, excitatory amino acid antagonists, strategies to improve mitochondrial function, free radical scavengers, and trophic factors. All of these approaches appear promising in experimental studies and are now being applied to human studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
Boveris, A., & Chance, B. (1973) · Biochemical Journal · doi:10.1042/bj1340707 · Cited by 2,626
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,233
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6368 · Cited by 2,174
Normal oxidative damage to mitochondrial and nuclear DNA is extensive.
Richter, C., Park, J. W., & Ames, B. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6465 · Cited by 1,725
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
Turrens, J. F., & Boveris, A. (1980) · Biochemical Journal · doi:10.1042/bj1910421 · Cited by 1,601
Effects of Cerebral Ischemia in Mice Deficient in Neuronal Nitric Oxide Synthase
Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman, M. C., & Moskowitz, M. A. (1994) · Science · doi:10.1126/science.7522345 · Cited by 1,565
Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase
Deng, H.-X., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,477
Cited by
Items 101–173 of 173
2,7‐Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation
Possel, H., Noack, H., Augustin, W., Keilhoff, G., & Wolf, G. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01197-6 · Cited by 283
Cognitive Decline Is Associated with Systemic Oxidative Stress: The EVA Study
Berr, C., Balansard, B., Arnaud, J., Roussel, A., Alpérovitch, A., & EVA Study Group (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb02603.x · Cited by 281
Analysis of European mitochondrial haplogroups with Alzheimer disease risk
van der Walt, J. M., Dementieva, Y. A., Martin, E. R., Scott, W. K., Nicodemus, K. K., Kroner, C. C., Welsh-Bohmer, K. A., Saunders, A. M., Roses, A. D., Small, G. W., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.04.051 · Cited by 280
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Witte, M. E., Mahad, D. J., Lassmann, H., & van Horssen, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.007 · Cited by 278
Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., & Murphy, T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414635200 · Cited by 273
Kwong, L. K., & Sohal, R. S. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1495 · Cited by 273
Pennathur, S., Jackson-Lewis, V., Przedborski, S., & Heinecke, J. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34621 · Cited by 265
Peña-Llopis, S., Ferrando, M. D., & Peña, J. B. (2003) · Aquatic Toxicology · doi:10.1016/s0166-445x(03)00148-6 · Cited by 264
Tyrosine Hydroxylase and Parkinson’s Disease
Haavik, J., & Toska, K. (1998) · Molecular Neurobiology · doi:10.1007/bf02741387 · Cited by 263
Wiedemann, F. R., Winkler, K., Kuznetsov, A. V., Bartels, C., Vielhaber, S., Feistner, H., & Kunz, W. S. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00008-2 · Cited by 262
Choi, W.-S., Yoon, S.-Y., Oh, T. H., Choi, E.-J., O'Malley, K. L., & Oh, Y. J. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990701)57:1<86::aid-jnr9>3.0.co;2-e · Cited by 261
Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity
Cardoso, S. M., Santana, I., Swerdlow, R. H., & Oliveira, C. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02438.x · Cited by 261
MECHANISMS OF RADIATION INJURY TO THE CENTRAL NERVOUS SYSTEM: IMPLICATIONS FOR NEUROPROTECTION
Wong, C. S. (2004) · Molecular Interventions · doi:10.1124/mi.4.5.7 · Cited by 259
Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., Lee, C. S., McKenzie, J., McCormick, S., Samii, A., Troiano, A., et al. (2009) · Brain · doi:10.1093/brain/awp209 · Cited by 259
Vielhaber, S. (2000) · Brain · doi:10.1093/brain/123.7.1339 · Cited by 258
. Chun, H. S., Gibson, G. E., DeGiorgio, L. A., Zhang, H., Kidd, V. J., & Son, J. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00096.x · Cited by 256
Bhakat, K. K., Mantha, A. K., & Mitra, S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2198 · Cited by 255
Finkbeiner, S. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007476 · Cited by 255
Ca2+–Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration
Weiss, J. H., & Sensi, S. L. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01610-6 · Cited by 255
Zhu, J., Guo, F., Shelburne, J., Watkins, S., & Chu, C. T. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00478.x · Cited by 255
Prion Protein Accumulation and Neuroprotection in Hypoxic Brain Damage
McLennan, N. F., Brennan, P. M., McNeill, A., Davies, I., Fotheringham, A., Rennison, K. A., Ritchie, D., Brannan, F., Head, M. W., Ironside, J. W., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63291-9 · Cited by 252
Sheehan, J. P., Swerdlow, R. H., Miller, S. W., Davis, R. E., Parks, J. K., Parker, W. D., & Tuttle, J. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04612.1997 · Cited by 249
Calkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W., & Johnson, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408487101 · Cited by 247
Truban, D., Hou, X., Caulfield, T. R., Fiesel, F. C., & Springer, W. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160989 · Cited by 237
Dementia, stroke, and vascular risk factors; a review
Sahathevan, R., Brodtmann, A., & Donnan, G. A. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00731.x · Cited by 230
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease
Mecocci, P. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.794 · Cited by 229
“The brain is particularly susceptible to the attack of free radicals caused by its low content of antioxidants, by the considerable content of polyunsaturated fatty acid side chains of the neuronal membrane lipids, and by its high oxygen consumption rate.(2,3) Furthermore, aging—a major risk factor for AD—is known to…”
BackgroundOxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects
Wojsiat, J., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6435861 · Cited by 221
Petit-Taboué, M. C., Landeau, B., Desson, J. F., Desgranges, B., & Baron, J. C. (1998) · NeuroImage · doi:10.1006/nimg.1997.0318 · Cited by 221
Behl, C., & Moosmann, B. (2002) · Biological Chemistry · doi:10.1515/bc.2002.053 · Cited by 203
Functional mitochondria are required for amyloid β‐mediated neurotoxicity
Cardoso, S. M., Santos, S., Swerdlow, R. H., & Oliveira, C. R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0561fje · Cited by 203
“Other data suggest that bioenergetic failure resulting from depressed cytochrome c oxidase activity and reactive oxygen species (ROS) overproduction could contribute to neuronal death in AD (6, 7, 8).”
BackgroundGuo, Q., Robinson, N., & Mattson, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12341 · Cited by 196
Synthesis and transport of creatine in the CNS: Importance for cerebral functions
Béard, E., & Braissant, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06935.x · Cited by 192
Extraction of coffee antioxidants: Impact of brewing time and method
Ludwig, I. A., Sanchez, L., Caemmerer, B., Kroh, L. W., De Peña, M. P., & Cid, C. (2012) · Food Research International · doi:10.1016/j.foodres.2012.02.023 · Cited by 185
“INTRODUCTION Several chronic diseases, such as cancer, cardiovascular, inflammatory, and neurogenerative pathologies are associated with oxidative stress (Aruoma, 1999; Beal, 1995; Dorea & da Costa, 2005).”
BackgroundNelson, L. M., McGuire, V., Longstreth, W. T., & Matkin, C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010183 · Cited by 174
A review of neuroimaging findings in repetitive brain trauma
Koerte, I. K., Lin, A. P., Willems, A., Muehlmann, M., Hufschmidt, J., Coleman, M. J., Green, I., Liao, H., Tate, D. F., Wilde, E. A., et al. (2015) · Brain Pathology · doi:10.1111/bpa.12249 · Cited by 160
Hypothesis: Ataxia‐telangiectasia: Is ATM a sensor of oxidative damage and stress?
Rotman, G., & Shiloh, Y. (1997) · BioEssays · doi:10.1002/bies.950191011 · Cited by 160
Idebenone treatment fails to slow cognitive decline in Alzheimer’s disease
Thal, L. J., Grundman, M., Berg, J., Ernstrom, K., Margolin, R., Pfeiffer, E., Weiner, M. F., Zamrini, E., & Thomas, R. G. (2003) · Neurology · doi:10.1212/01.wnl.0000096376.03678.c1 · Cited by 156
Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender
Craft, S., Asthana, S., Schellenberg, G., Cherrier, M., Baker, L. D., Newcomer, J., Plymate, S., Latendresse, S., Petrova, A., Raskind, M., et al. (1999) · Neuroendocrinology · doi:10.1159/000054469 · Cited by 154
Han, J., Miyamae, Y., Shigemori, H., & Isoda, H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.049 · Cited by 146
Simon, D. K., Pulst, S. M., Sutton, J. P., Browne, S. E., Beal, M. F., & Johns, D. R. (1999) · Neurology · doi:10.1212/wnl.53.8.1787 · Cited by 141
Self-citationAge-related changes in the regulation of transcription factor NF-κB in rat brain
Korhonen, P., Helenius, M., & Salminen, A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00190-0 · Cited by 138
Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138
“An impairment of energy metabolism characterizes the AD brain [74].”
BackgroundAbe, T., Tohgi, H., Isobe, C., Murata, T., & Sato, C. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10349 · Cited by 124
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain
Hardas, S. S., Sultana, R., Clark, A. M., Beckett, T. L., Szweda, L. I., Murphy, M. P., & Butterfield, D. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.002 · Cited by 120
“Previous studies from our laboratory and other showed that HNE levels are elevated in AD, and the oxidative modification of the proteins affects the structure and function of proteins [3,8,17,32,33].”
BackgroundQuinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer’s disease
Raina, A. K., Templeton, D. J., deak, J. C., Perry, G., & Smith, M. A. (1999) · Redox Report · doi:10.1179/135100099101534701 · Cited by 120
Mitochondrial function impairment induced by amyloid β-peptide on PC12 cells
Pereira, C., Santos, M. S., & Oliveira, C. (1998) · NeuroReport · doi:10.1097/00001756-199806010-00015 · Cited by 115
In Vitro and ex Vivo Antihydroxyl Radical Activity of Green and Roasted Coffee
Daglia, M., Racchi, M., Papetti, A., Lanni, C., Govoni, S., & Gazzani, G. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030298n · Cited by 113
Mitochondria, Cybrids, Aging, and Alzheimer's Disease
Swerdlow, R. H., Koppel, S., Weidling, I., Hayley, C., Ji, Y., & Wilkins, H. M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.12.017 · Cited by 106
Parihar, M. S., & Hemnani, T. (2003) · Journal of Biosciences · doi:10.1007/bf02970142 · Cited by 102
“Excitotoxicity is a contributing factor to the pathogenesis of neurodegenerative disorders such as Alzheimer’s dis- ease (Law et al 2001) and Parkinson’s disease (Beal 1995; Hantraye et al 1996).”
BackgroundMitochondria and aging: A role for the permeability transition?
Crompton, M. (2004) · Aging Cell · doi:10.1046/j.1474-9728.2003.00073.x · Cited by 101
Tikka, T., Usenius, T., Tenhunen, M., Keinänen, R., & Koistinaho, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00543.x · Cited by 96
Olivares, D., Huang, X., Branden, L., Greig, N. H., & Rogers, J. T. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031226 · Cited by 93
“impairment of cellular antioxidative mechanisms and/or overproduction of reactive oxygen species (ROS) may cause the initiation and progression of neurodegenerative synucleinopathies [109].”
BackgroundMitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology
Nagy, Z., Esiri, M. M., LeGris, M., & Matthews, P. M. (1999) · Acta Neuropathologica · doi:10.1007/s004010050997 · Cited by 85
“It has also been found that COX is differentially distributed and activated in different compartments of the cell according to the cell's physiological activity and local energy requirements [ 1 , 6, 9, 10, 29].”
BackgroundLiu, G.-S., Zhang, Z.-S., Yang, B., & He, W. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.08.033 · Cited by 82
Gao, Y., Ray, S., Dai, S., Ivanov, A. R., Abu‐Absi, N. R., Lewis, A. M., Huang, Z., Xing, Z., Borys, M. C., Li, Z. J., et al. (2016) · Biotechnology Journal · doi:10.1002/biot.201600030 · Cited by 76
Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients
Curti, D., Rognoni, F., Gasparini, L., Cattaneo, A., Paolillo, M., Racchi, M., Zani, L., Bianchetti, A., Trabucchi, M., Bergamaschi, S., et al. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00741-6 · Cited by 80
Obesity exacerbates chemically induced neurodegeneration
Sriram, K., Benkovic, S. A., Miller, D. B., & O’Callaghan, J. P. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00306-8 · Cited by 78
Toward understanding genomic instability, mitochondrial dysfunction and aging
Fakouri, N. B., Hou, Y., Demarest, T. G., Christiansen, L. S., Okur, M. N., Mohanty, J. G., Croteau, D. L., & Bohr, V. A. (2019) · The FEBS Journal · doi:10.1111/febs.14663 · Cited by 77
Are lutein, lycopene, and β-carotene lost through the digestive process?
Kopec, R. E., Gleize, B., Borel, P., Desmarchelier, C., & Caris-Veyrat, C. (2017) · Food & Function · doi:10.1039/c7fo00021a · Cited by 72
Faizi, M., Salimi, A., Seydi, E., Naserzadeh, P., Kouhnavard, M., Rahimi, A., & Pourahmad, J. (2016) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2016.1172284 · Cited by 71
Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by α-lipoic acid
Gatei, M., Shkedy, D., Khanna, K. K., Uziel, T., Shiloh, Y., Pandita, T. K., Lavin, M. F., & Rotman, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204111 · Cited by 68
The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro
Cammer, W. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00181-1 · Cited by 65
Xu, P., Wang, K., Lu, C., Dong, L., Gao, L., Yan, M., Aibai, S., & Liu, X. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.08.030 · Cited by 64
Mass spectrometric analysis of protein tyrosine nitration in aging and neurodegenerative diseases
Yeo, W., Kim, Y. J., Kabir, M. H., Kang, J. W., & Kim, K. P. (2015) · Mass Spectrometry Reviews · doi:10.1002/mas.21429 · Cited by 61
Age- and brain region-specific differences in mitochondrial bioenergetics in Brown Norway rats
Pandya, J. D., Royland, J. E., MacPhail, R. C., Sullivan, P. G., & Kodavanti, P. R. S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.027 · Cited by 50
Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47
“It has been reported that the AD patients are characterized by increased level and activity of ROS [272] due to the deposition of Aβ [273], activation of microglia cells [274], neuronal mitochondrial dysfunctioning [275], disturbance in the redox metal metabolic pathway [63, 64, 276], and the deficiencies of neurotran…”
BackgroundMitochondrial medicine and the neurodegenerative mitochondriopathies
Swerdlow, R. H. (2009) · Pharmaceuticals · doi:10.3390/ph2030150 · Cited by 43
“studies further suggest this arises as a consequence of complex I dysfunction [7,27,34].”
BackgroundLamigeon, C., Bellier, J. P., Sacchettoni, S., Rujano, M., & Jacquemont, B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00278.x · Cited by 41
Bhattacharya, K., Maiti, S., Zahoran, S., Weidenauer, L., Hany, D., Wider, D., Bernasconi, L., Quadroni, M., Collart, M., & Picard, D. (2022) · Nature Communications · doi:10.1038/s41467-022-33916-3 · Cited by 40
Bortoluzzi, V. T., de Franceschi, I. D., Rieger, E., & Wannmacher, C. M. D. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1353-8 · Cited by 19
Li, X., Li, T., Zhan, F., Cheng, F., Lu, L., Zhang, B., Li, J., Hu, Z., Zhou, S., Jia, Y., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00520 · Cited by 18
Chowdhury, T., Allen, M. F., Thorn, T. L., He, Y., & Hewett, S. J. (2018) · Antioxidants · doi:10.3390/antiox7080100 · Cited by 18
Lamigeon, C., Prod'Hon, C., De Frias, V, Michoudet, C., & Jacquemont, B. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00400-x · Cited by 13
Metadata
- Authors
- Beal, M. F.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1995-09
- Volume
- 38
- Issue
- 3
- Pages
- 357-366
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2140075873
- Cited by
- 1,440
- References
- 106
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.